10-Q Filing

ACUTUS MEDICAL, INC. CIK: 1522860 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-027091`
Period End Date	20210331
Filing Date	20210513
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	afib-10q_20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 35 Cash Flow Statement 67 Stockholders Equity 17

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.23M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.63M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$86.89M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$105.84M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.48M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.16M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	28.11M	shares	Point-in-time
Inventory	`InventoryNet`	$12.96M	USD	Point-in-time
Inventory	`InventoryNet`	$13.84M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.99M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.99M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	28.11M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.12M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$116.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.39M	USD	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$8.73M	USD	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$11.22M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.36M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$1.48M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$1.67M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.49M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.65M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$967.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$717.00K	USD	Point-in-time
Total assets	`Assets`	$192.53M	USD	Point-in-time
Total assets	`Assets`	$161.95M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.11M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$8.81M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.31M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$5.40M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$2.60M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$955.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$933.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.91M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.13M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$875.00K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.34M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.01M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.90M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$61.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$65.95M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of March 31, 2021 and December 31, 2020; no shares issued and outstanding as of March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of March 31, 2021 and December 31, 2020; no shares issued and outstanding as of March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 28,113,165 and 27,991,425 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 28,113,165 and 27,991,425 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$490.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$487.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-390.20M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$60.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$280.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$161.95M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$192.53M	USD	Point-in-time

Income Statement 35 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.58M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.59M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$6.96M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$3.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.37M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.97M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.23M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$16.25M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-2.22M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.15M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$31.42M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$19.18M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-27.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-17.60M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-581.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$40.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$275.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.35M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.39M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-498.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.35M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.10M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.10M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$6.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-27.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-226.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-18.15M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-29.40M	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-25.84	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.04	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.03M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	700,505.00	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-18.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-29.18M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.24M	USD	1 Quarter
Depreciation expense	`Depreciation`	$429.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$160.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$110.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.91M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.74M	USD	1 Quarter
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-412.00K	USD	1 Quarter
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$154.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$328.00K	USD	1 Quarter
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$169.00K	USD	1 Quarter
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$180.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-581.00K	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-2.22M	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.15M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$708.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$317.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$1.81M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$879.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-214.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.10M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$267.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$250.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.60M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.09M	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.50M	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-83.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-237.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-207.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.27M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-17.56M	USD	1 Quarter
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$9.13M	USD	1 Quarter
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$8.10M	USD	1 Quarter
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$25.00M	USD	1 Quarter
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$25.30M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.69M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.68M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$12.17M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$31.72M	USD	1 Quarter
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.55M	USD	1 Quarter
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.58M	USD	1 Quarter
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$169.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.58M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.38M	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-124.00K	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-27.00K	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.55M	USD	1 Quarter
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-16.60M	USD	1 Quarter
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	$35.00K	USD	1 Quarter
Cash paid for interest	`InterestPaid`	$1.19M	USD	1 Quarter
Cash paid for interest	`InterestPaid`	$1.12M	USD	1 Quarter
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	1 Quarter
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	1 Quarter
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$-6.00K	USD	1 Quarter
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$27.00K	USD	1 Quarter
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$119.00K	USD	1 Quarter
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$-67.00K	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$6.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-27.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-226.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$169.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.91M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$1.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.10M	USD	1 Quarter
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.